CL2018002347A1 - Nuevos derivados pirrolidina - Google Patents
Nuevos derivados pirrolidinaInfo
- Publication number
- CL2018002347A1 CL2018002347A1 CL2018002347A CL2018002347A CL2018002347A1 CL 2018002347 A1 CL2018002347 A1 CL 2018002347A1 CL 2018002347 A CL2018002347 A CL 2018002347A CL 2018002347 A CL2018002347 A CL 2018002347A CL 2018002347 A1 CL2018002347 A1 CL 2018002347A1
- Authority
- CL
- Chile
- Prior art keywords
- pyrrolidine derivatives
- new pyrrolidine
- new
- formula compound
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA INVENCIÓN SE REFIERE A UN COMPUESTO DE FÓRMULA (I), EN LA QUE R1 Y R2 SON TAL COMO SE DEFINE EN LA DESCRIPCIÓN Y EN LAS REIVINDICACIONES. EL COMPUESTO DE FÓRMULA (I) PUEDE UTILIZARSE COMO MEDICAMENTO.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16157679 | 2016-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2018002347A1 true CL2018002347A1 (es) | 2018-11-30 |
Family
ID=55443159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2018002347A CL2018002347A1 (es) | 2016-02-26 | 2018-08-16 | Nuevos derivados pirrolidina |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US10689339B2 (es) |
| EP (1) | EP3419970B1 (es) |
| JP (1) | JP6952044B2 (es) |
| KR (1) | KR102797060B1 (es) |
| CN (1) | CN108699044B (es) |
| AR (1) | AR107717A1 (es) |
| AU (1) | AU2017224343B2 (es) |
| CA (1) | CA3011652C (es) |
| CL (1) | CL2018002347A1 (es) |
| CO (1) | CO2018007756A2 (es) |
| CR (1) | CR20180404A (es) |
| DK (1) | DK3419970T3 (es) |
| ES (1) | ES2775781T3 (es) |
| HR (1) | HRP20200307T1 (es) |
| HU (1) | HUE047842T2 (es) |
| IL (1) | IL260130B (es) |
| LT (1) | LT3419970T (es) |
| MA (1) | MA43667B1 (es) |
| MX (1) | MX381332B (es) |
| MY (1) | MY196560A (es) |
| PH (1) | PH12018501585B1 (es) |
| PL (1) | PL3419970T3 (es) |
| PT (1) | PT3419970T (es) |
| RS (1) | RS59938B1 (es) |
| RU (1) | RU2736498C1 (es) |
| SG (1) | SG11201807074VA (es) |
| SI (1) | SI3419970T1 (es) |
| TW (1) | TWI740903B (es) |
| UA (1) | UA122084C2 (es) |
| WO (1) | WO2017144483A1 (es) |
| ZA (1) | ZA201804120B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3575284T3 (pl) | 2017-01-24 | 2021-12-27 | Astellas Pharma Inc. | Związek prolinamidu podstawiony fenylodifluorometylem |
| TWI846731B (zh) | 2018-09-18 | 2024-07-01 | 瑞士商赫孚孟拉羅股份公司 | 組織蛋白酶(cathepsin)S抑制劑之對抗抗藥抗體形成之用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ595073A (en) * | 2009-04-20 | 2012-11-30 | Hoffmann La Roche | Proline derivatives as cathepsin inhibitors |
| CN103930400B (zh) * | 2011-11-11 | 2016-04-20 | 霍夫曼-拉罗奇有限公司 | 制备1-酰基-4-苯基磺酰基脯氨酰胺衍生物的方法及中间体 |
| RU2014123784A (ru) * | 2011-11-25 | 2015-12-27 | Ф. Хоффманн-Ля Рош Аг | Новые производные пирролидина в качестве ингибиторов катепсина |
| CN104114068B (zh) * | 2011-12-09 | 2017-07-11 | W.C.布拉德利公司 | 具有可调整的加热特征的烹饪炉排 |
| EP2814822B1 (en) * | 2012-02-17 | 2016-04-20 | F.Hoffmann-La Roche Ag | Novel pyrrolidine derivatives |
| PE20150995A1 (es) * | 2012-08-21 | 2015-06-29 | Hoffmann La Roche | Nuevos derivados de piridina |
-
2017
- 2017-02-22 CN CN201780013397.XA patent/CN108699044B/zh active Active
- 2017-02-22 UA UAA201809397A patent/UA122084C2/uk unknown
- 2017-02-22 CA CA3011652A patent/CA3011652C/en active Active
- 2017-02-22 WO PCT/EP2017/053967 patent/WO2017144483A1/en not_active Ceased
- 2017-02-22 SG SG11201807074VA patent/SG11201807074VA/en unknown
- 2017-02-22 PL PL17705662T patent/PL3419970T3/pl unknown
- 2017-02-22 CR CR20180404A patent/CR20180404A/es unknown
- 2017-02-22 KR KR1020187024347A patent/KR102797060B1/ko active Active
- 2017-02-22 AU AU2017224343A patent/AU2017224343B2/en active Active
- 2017-02-22 MY MYPI2018001465A patent/MY196560A/en unknown
- 2017-02-22 RU RU2018133640A patent/RU2736498C1/ru active
- 2017-02-22 SI SI201730195T patent/SI3419970T1/sl unknown
- 2017-02-22 MA MA43667A patent/MA43667B1/fr unknown
- 2017-02-22 EP EP17705662.9A patent/EP3419970B1/en active Active
- 2017-02-22 HU HUE17705662A patent/HUE047842T2/hu unknown
- 2017-02-22 DK DK17705662.9T patent/DK3419970T3/da active
- 2017-02-22 JP JP2018541661A patent/JP6952044B2/ja active Active
- 2017-02-22 LT LTEP17705662.9T patent/LT3419970T/lt unknown
- 2017-02-22 ES ES17705662T patent/ES2775781T3/es active Active
- 2017-02-22 HR HRP20200307TT patent/HRP20200307T1/hr unknown
- 2017-02-22 PT PT177056629T patent/PT3419970T/pt unknown
- 2017-02-22 MX MX2018009638A patent/MX381332B/es unknown
- 2017-02-22 RS RS20200183A patent/RS59938B1/sr unknown
- 2017-02-24 TW TW106106388A patent/TWI740903B/zh active
- 2017-02-24 AR ARP170100467A patent/AR107717A1/es unknown
-
2018
- 2018-06-19 IL IL260130A patent/IL260130B/en active IP Right Grant
- 2018-06-20 ZA ZA2018/04120A patent/ZA201804120B/en unknown
- 2018-07-25 PH PH12018501585A patent/PH12018501585B1/en unknown
- 2018-07-26 CO CONC2018/0007756A patent/CO2018007756A2/es unknown
- 2018-08-16 CL CL2018002347A patent/CL2018002347A1/es unknown
- 2018-08-24 US US16/111,721 patent/US10689339B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2023000198A1 (es) | Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo | |
| SV2018005792A (es) | Nuevos derivados piperidinilo sustituidos con hetero (arilo), un proceso para su preparacion y composiciones farmaceuticas que los contienen | |
| CL2018003474A1 (es) | Nuevos derivados piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen. | |
| CO2017005790A2 (es) | Derivados heterocíclicos con sustituyentes que contienen azufre activos como plaguicidas | |
| CO2017013709A2 (es) | Lactamas bicíclicas. | |
| CR20150440A (es) | Nuevos derivados de piridina | |
| CR20160503A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos, como fungicidas | |
| CR20160459A (es) | Nuevos derivados de piridina | |
| CR20150250A (es) | Nuevos derivados de piridina | |
| CL2017001100A1 (es) | Nuevas triazolo[4,5-d]pirimidinas | |
| CL2018001493A1 (es) | Nuevos derivados de fenilo | |
| CR20160448A (es) | Nuevos derivados de piridina | |
| CR20170008A (es) | Compuestos de [1,2,4] triazol e imidazol sustituidos | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CR20170090A (es) | Derivados de terahidroquinolina como inhibidores del bromodominio | |
| CL2018003610A1 (es) | Nuevos derivados de [1,2,3]triazolo[4,5-d]pirimidina. | |
| PY1515461A (es) | Derivados de Dihidropirrolopirimidina | |
| GT201600232A (es) | Derivados de diheterociclo enlazado a cicloalquilo | |
| MX363458B (es) | Nuevos derivados de tetrazolona. | |
| CO2018007756A2 (es) | Nuevos derivados pirrolidina | |
| CO7200259A2 (es) | Nuevos derivados de piridina | |
| CR20170183A (es) | Nuevas triazolo[4,5-d]pirimidinas |